Wikipedia -WSS

Wikipedia

author：focus 2025-09-28 22:28:49 - browse：3

Palm Drive at Stanford University on March 28, 2023 — Palm Drive at the entrance to Stanford University. Brian Frank for STAT

The resignation of Marc Tessier-Lavigne as president of Stanford University following an investigation into irregularities in his past research marks more than just the startling downfall of the leader of one of the nation’s top research powerhouses. The case is likely to have broader repercussions, signaling a tipping point in an ongoing and often contentious debate about how to assign blame and credit in the increasingly collaborative world of research.

Science is a team sport. And while the lab leaders, or principal investigators, often get most of the attention for biomedical breakthroughs, they seldom run experiments. That work is left to postdoctoral researchers, graduate students, and others who peer through microscopes, labor away in mouse rooms, and spend countless hours pipetting. Instead, professors play more of a managerial role, supervising, critiquing, and offering big-picture feedback on the work that goes on in their lab.

It’s a longstanding arrangement, but one that leads to a thorny question when research is challenged: Who’s to blame? STAT put that question to Stanford faculty and students while reporting earlier this year on allegations of image manipulation and other misconduct related to research in Tessier-Lavigne’s lab, as well as researchers at other institutions. The answer varied depending on whom you asked.

Graduate students stressed that since faculty have no qualms using work done in their labs to land grants, win prizes, and build prestige, they should ultimately be accountable for problems with the science done under their supervision. Faculty generally agree, at least in principle, but are often quick to say that there are limits to how closely they can scrutinize their lab’s work, and that team science is in part based on trust. It’s an argument Tessier-Lavigne cited in his own statement about his resignation.

It’s also one he said wasn’t good enough.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Novo Nordisk to buy Cardior, building up pipeline of heart drugs

WSS

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

With Wegovy coverage, Medicare patients may face high costs

Pregnancy ages women, but effects reverse after delivery

What the airline industry can learn from medicine

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Vertex non

leisure time

Wikipedia

hotspot

Peter Hotez and the public health issue of online harassment

‘Oppenheimer’ and the risks of AI in health care

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Illumina, CRISPR, Regeneron

Cancer drug shortages should be causing more outrage

NIH launches clinical trials and new research office for long Covid

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

'Patient friction coefficient' can gauge a clinical trial's patient burden

entertainment

Chinese researcher claims birth of first gene

Mirador, a new biotech startup, launches with $400 million

Mirador, a new biotech startup, launches with $400 million

Testing GLP

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Pregnancy ages women, but effects reverse after delivery

hotspot

explore

knowledge

Wikipedia